scispace - formally typeset
J

Juhye Kang

Researcher at KAIST

Publications -  26
Citations -  1067

Juhye Kang is an academic researcher from KAIST. The author has contributed to research in topics: Medicine & Protein aggregation. The author has an hindex of 12, co-authored 23 publications receiving 711 citations. Previous affiliations of Juhye Kang include Pohang University of Science and Technology & Ulsan National Institute of Science and Technology.

Papers
More filters
Journal ArticleDOI

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

TL;DR: Possible therapeutic targets in Alzheimer's disease, Parkinson's Disease, and amyotrophic lateral sclerosis are outlined and molecules, previously designed or discovered as potential drug candidates for these disorders with emphasis on multifunctionality are discussed.
Journal ArticleDOI

Endoplasmic Reticulum-Localized Iridium(III) Complexes as Efficient Photodynamic Therapy Agents via Protein Modifications

TL;DR: The Ir(III) complexes are effective as PDT agents at low concentrations with low-energy irradiation because of the relatively high (1)O2 quantum yield (> 0.78), even with two-photon activation.
Journal ArticleDOI

Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.

TL;DR: It is reported that DA and its rationally designed structural derivatives based on DA's oxidative transformation are able to modulate multiple pathological elements found in AD with demonstration of detailed molecular-level mechanisms.
Journal ArticleDOI

Mechanistic Insights into Tunable Metal-Mediated Hydrolysis of Amyloid-β Peptides

TL;DR: A novel approach to validate the hydrolytic cleavage of divalent metal complexes toward two major isoforms of Aβ and tune their proteolytic activity based on the choice of metal centers which could be correlated to their anti-amyloidogenic properties is reported.
Journal ArticleDOI

Strategies Employing Transition Metal Complexes To Modulate Amyloid-β Aggregation.

TL;DR: A greater understanding of how transition metal complexes have been engineered and used for alteration of Aβ aggregation could provide insight into the new discovery of chemical reagents against Aβ peptides found in AD.